- Home
- SARO vs ASND Comparison
SARO vs ASND Comparison
Compare SARO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SARO
- ASND
- Stock Information
- Founded
- SARO 1911
- ASND 2006
- Country
- SARO United States
- ASND Denmark
- Employees
- SARO N/A
- ASND N/A
- Industry
- SARO
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- SARO
- ASND Health Care
- Exchange
- SARO NYSE
- ASND Nasdaq
- Market Cap
- SARO 9.0B
- ASND 9.9B
- IPO Year
- SARO 2024
- ASND 2015
- Fundamental
- Price
- SARO $26.82
- ASND $151.43
- Analyst Decision
- SARO Buy
- ASND Strong Buy
- Analyst Count
- SARO 8
- ASND 14
- Target Price
- SARO $34.50
- ASND $201.79
- AVG Volume (30 Days)
- SARO 3.6M
- ASND 409.7K
- Earning Date
- SARO 03-10-2025
- ASND 05-01-2025
- Dividend Yield
- SARO N/A
- ASND N/A
- EPS Growth
- SARO N/A
- ASND N/A
- EPS
- SARO 0.04
- ASND N/A
- Revenue
- SARO $5,237,161,000.00
- ASND $376,478,932.00
- Revenue This Year
- SARO $13.71
- ASND $61.43
- Revenue Next Year
- SARO $10.71
- ASND $73.07
- P/E Ratio
- SARO $711.19
- ASND N/A
- Revenue Growth
- SARO 14.77
- ASND 36.34
- 52 Week Low
- SARO $22.50
- ASND $111.09
- 52 Week High
- SARO $34.38
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- SARO N/A
- ASND 47.14
- Support Level
- SARO N/A
- ASND $143.81
- Resistance Level
- SARO N/A
- ASND $161.91
- Average True Range (ATR)
- SARO 0.00
- ASND 6.32
- MACD
- SARO 0.00
- ASND -1.66
- Stochastic Oscillator
- SARO 0.00
- ASND 29.81
About SARO STANDARDAERO INC.
StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.